KDA Group Inc. announced that Dr. Giuseppe D'Aprano is appointed to the Corporation's management team as Chief Scientific Officer (CSO) as of June 26, 2019. In his new role, Dr. Giuseppe D'Aprano and his team will be responsible for the development strategy of the cannabis products with the collaboration of various Key Opinion Leaders (KOLs), Good Manufacturing Practices (GMP) certification, compliance and portfolio management of the Corporation.